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A healthy placenta is critical for a healthy pregnancy.
Conversely, abnormal placental structure and function is
seen in conditions which are associated with stillbirth
including: fetal growth restriction, preeclampsia, placen-
tal abruption and obstetric cholestasis. Abnormalities
can be seen ranging from a reduction in placental size
in stillbirth to microscopic changes in placental villous
architecture [1]. Placental examination is advocated after
stillbirth by respected guidelines [2-4]; this recommen-
dation is based upon the frequency of abnormalities
seen in placentas after stillbirth [5,6], the reduction in
unexplained stillbirths when placental histological exam-
ination is performed and the cost-effectiveness per
abnormality detected [1,7].
The placenta has previously been referred to as a “diary
of pregnancy” and it is tempting to compare examination
of the placenta after stillbirth with the “black-box” flight
data recorder used after aircraft accidents. To be certain
that placental findings are significant in a case of stillbirth
they should reflect (relevant) changes that occurred prior
to fetal death. Thus, there should be no artefact from in-
utero retention or storage. Placental findings should give
information regarding conditions present and be specific
for adverse pregnancy outcome (i.e. not occur in healthy
pregnancy). Ultimately, the information obtained must be
useful, aiding understanding of death by clinicians and
inform future care.
Storage and fixation of placental tissue can alter find-
ings on examination. Naeye et al. states that “trouble-
some artefacts” can appear after 48 hours of
refrigeration [8]. This is supported by qualitative and
quantitative assessment Garrod et al. demonstrated
changes in villous vascularity after 48 hours refrigeration
[9]. Thus, every effort should be made to minimise the
time of storage prior to examination. The effects of
retention in utero before birth are more difficult to
assess as the time of fetal death is usually unknown.
Genest estimated that in utero retention was associated
with villous degeneration, particularly of fetal blood ves-
sels and villous stroma [10].
A systematic review of histopathological assessment of
the placenta found that a placental cause is reported in
11.2 - 64.9% and associated with stillbirth in 31.5% -
84% of cases [11]. The greatest influence on the propor-
tion of stillbirths classified as having “placental”
abnormalities was the classification system employed.
The specificity of placental abnormalities for stillbirth
has previously been questioned by the high incidence of
histological lesions in apparently normal pregnancies
and the large variation in agreement between patholo-
gists when identifying lesions (Kappa – 0.25-0.91)
[12,13]. These data highlight the importance of interna-
tional consensus in the definition of placental lesions to
improve study quality. Accurate description of lesions
will also enable better understanding of their origins.
One example of this is syncytial knots (also known as
syncytial nuclear aggregates). The formation of syncytial
knots are increased in hypoxia and oxidative stress in
vitro [14], which supports the reported association
between syncytial knots/nuclear aggregates and maternal
vascular malperfusion [13,15].
Furthermore, evaluation of placental structure and
function can be used to explore clinical scenarios relat-
ing to stillbirth such as maternal perception of reduced
fetal movements, advanced maternal age and fetal
growth restriction [16-18]. These clinical conditions are
all associated with alterations in placental structure, spe-
cifically increased syncytial knots/nuclear aggregates,
changes in trophoblast proliferation and alterations in
amino-acid transport [14,19-21]. Importantly, these
observations provide plausible biological association
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between these clinical scenarios and stillbirth from pla-
cental causes. These suggest that better appreciation of
placental function in utero may provide an opportunity
to identify pregnancies at risk of stillbirth to target
intervention [22,23].
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